Rite Aid (NYSE:RAD) has been one of the great comeback stories of the last decade. Not only have its shares risen over 700% since bottoming out at the end of 2012, but its bottom line has swung from an eye-popping $555 million loss in fiscal year 2011 to a more than respectable profit of $249 million last year.

If this turnaround isn't enough to convince you, Rite Aid might have an even bigger ace up its sleeve. As Motley Fool consumer goods analyst Sean O'Reilly explains, Rite Aid is just beginning to roll out a new initiative that has potentially major implications not only for its shareholders but for the health care industry itself.

Sean O'Reilly has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.